Advocacy intelligence hub — real-time data for patient organizations
Dana-Farber Cancer Institute — PHASE2
Timothy Yu — PHASE1, PHASE2
IntraBio Inc — PHASE3
EMD Serono Research & Development Institute, Inc. — PHASE2
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany — PHASE1
National Cancer Institute (NCI) — PHASE1, PHASE2
Memorial Sloan Kettering Cancer Center — PHASE2
University Hospital, Akershus — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Andreea Nissenkorn, MD
Sheba Medical Center, Pediatric Neurology and National A-T Clinic
Michael Goggins, MD, MB BCh BAO
Johns Hopkins University
📍 PHILADELPHIA, PA
Yoshiki Arakawa
Kyoto University Hospital
Hilde L Nilsen
University Hospital, Akershus
Amy Xu, MD, PhD
Memorial Sloan Kettering Cancer Center
Luca Benatti, MD
Quince Therapeutics S.p.A.